Terms: = Liver cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC AND Prognosis
10 results:
1. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy.
Zhang F; Wu J; Zhang L; Zhang J; Yang R
J Pharm Biomed Anal; 2024 Jun; 243():116073. PubMed ID: 38484637
[TBL] [Abstract] [Full Text] [Related]
2. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
4. Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
Li XF; Chen C; Xiang DM; Qu L; Sun W; Lu XY; Zhou TF; Chen SZ; Ning BF; Cheng Z; Xia MY; Shen WF; Yang W; Wen W; Lee TKW; Cong WM; Wang HY; Ding J
Hepatology; 2017 Dec; 66(6):1934-1951. PubMed ID: 28714104
[TBL] [Abstract] [Full Text] [Related]
5. RIPK1 Suppresses a TRAF2-Dependent Pathway to liver cancer.
Schneider AT; Gautheron J; Feoktistova M; Roderburg C; Loosen SH; Roy S; Benz F; Schemmer P; Büchler MW; Nachbur U; Neumann UP; Tolba R; Luedde M; Zucman-Rossi J; Panayotova-Dimitrova D; Leverkus M; Preisinger C; Tacke F; Trautwein C; Longerich T; Vucur M; Luedde T
Cancer Cell; 2017 Jan; 31(1):94-109. PubMed ID: 28017612
[TBL] [Abstract] [Full Text] [Related]
6. Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.
Matondo RB; Toussaint MJ; Govaert KM; van Vuuren LD; Nantasanti S; Nijkamp MW; Pandit SK; Tooten PC; Koster MH; Holleman K; Schot A; Gu G; Spee B; Roskams T; Rinkes IB; Schotanus B; Kranenburg O; de Bruin A
Oncotarget; 2016 Aug; 7(34):54662-54675. PubMed ID: 27323406
[TBL] [Abstract] [Full Text] [Related]
7. Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction.
Cai X; Feng L; Liu H; Xu M; Qu Y; Wan X; Gao C; Lu L
Ann Hepatol; 2016; 15(3):386-93. PubMed ID: 27049492
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer.
Lim H; Kim DH; Jung HY; Gong EJ; Na HK; Ahn JY; Kim MY; Lee JH; Choi KS; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2015 Mar; 9(2):159-65. PubMed ID: 25167869
[TBL] [Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma associated lipid metabolism reprogramming.
Skill NJ; Scott RE; Wu J; Maluccio MA
J Surg Res; 2011 Jul; 169(1):51-6. PubMed ID: 19932908
[TBL] [Abstract] [Full Text] [Related]
10. Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer.
Nakayama S; Takeda S; Kawase Y; Inoue S; Kaneko T; Nakao A
Ann Surg; 2004 Nov; 240(5):840-4. PubMed ID: 15492566
[TBL] [Abstract] [Full Text] [Related]
